Home > Boards > US Listed > Medical - Drugs > AIkido Pharma Inc (AIKI)

Its pretty mind blowing that they say they've

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
NYCPuglet Member Profile
 
Followed By 32
Posts 2,983
Boards Moderated 0
Alias Born 08/20/15
160x600 placeholder
AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching PR Newswire (US) - 9/14/2021 9:22:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2021 5:06:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/11/2021 4:17:52 PM
AIkido Provides Update on Use of Machine Learning in Drug Development Program PR Newswire (US) - 8/6/2021 10:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:19:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:19:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:19:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:19:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:18:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/30/2021 4:17:46 PM
Notice of Allowance Issued for Central Nervous System Peptide Technology PR Newswire (US) - 7/27/2021 10:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 4:16:23 PM
AIkido Pharma issues update on antiviral platform with University of Maryland Seeking Alpha - 7/16/2021 10:23:19 AM
AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland PR Newswire (US) - 7/16/2021 10:00:00 AM
AIkido Pharma to Attend the Alzheimer's Association International Conference PR Newswire (US) - 7/13/2021 10:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:16:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/23/2021 3:00:55 PM
AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease PR Newswire (US) - 6/23/2021 10:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 9:01:41 AM
AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 PR Newswire (US) - 6/4/2021 9:00:00 AM
AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Meeting PR Newswire (US) - 5/20/2021 9:17:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2021 9:01:14 AM
AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD... PR Newswire (US) - 5/12/2021 9:00:00 AM
AIkido Pharma reports Q1 results Seeking Alpha - 5/11/2021 9:20:41 AM
AIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate Update PR Newswire (US) - 5/11/2021 9:01:00 AM
NYCPuglet   Wednesday, 07/19/17 01:09:10 AM
Re: None
Post # of 8252 
Its pretty mind blowing that they say they've been around since 1967 then put this statement out:


"Since we have a limited operating history in our current business of patent licensing and monetization, it will make it difficult for investors and securities analysts to evaluate our business and prospects."

Wow. Just. Wow.

Can someone explain to me as a shareholder what the F this is?

I'm sure my post will get deleted. That's fine. I'm just stricken by all of the incriminating statements of ineptitude in this filing.

Thanks

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences